Climb Bio Inc (CLYM) USD0.0001

Sell:$4.90Buy:$5.44Price increased$0.79 (16.99%)

Prices delayed by at least 15 minutes
Sell:$4.90
Buy:$5.44
Change:Price increased$0.79 (16.99%)
Prices delayed by at least 15 minutes
Sell:$4.90
Buy:$5.44
Change:Price increased$0.79 (16.99%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 January 2026
RA CAPITAL MANAGEMENT LPHedge Fund
Buy
Regular purchase transaction
7,111$3.50$24,888.503,403,429
12 December 2025
RA CAPITAL MANAGEMENT LPHedge Fund
Buy
Regular purchase transaction
101,462$2.86$290,181.323,396,318
11 December 2025
RA CAPITAL MANAGEMENT LPHedge Fund
Buy
Regular purchase transaction
213,099$2.18$464,555.823,294,856
30 June 2025
Aoife M. BrennanPresident/CEO
Sell
Tax related
20,618$1.22$25,153.9648,132
20 June 2025
Emily PimblettChief Accounting Officer
Sell
Tax related
1,242$1.24$1,540.0818,888
20 March 2025
Emily PimblettChief Accounting Officer
Sell
Tax related
1,199$1.31$1,570.6915,130

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
11 December 2025
RA CAPITAL MANAGEMENT LPHedge Fund
Buy
Regular purchase transaction
213,099$2.18$464,555.823,294,856
12 December 2025
RA CAPITAL MANAGEMENT LPHedge Fund
Buy
Regular purchase transaction
101,462$2.86$290,181.323,396,318
30 June 2025
Aoife M. BrennanPresident/CEO
Sell
Tax related
20,618$1.22$25,153.9648,132
5 January 2026
RA CAPITAL MANAGEMENT LPHedge Fund
Buy
Regular purchase transaction
7,111$3.50$24,888.503,403,429
20 March 2025
Emily PimblettChief Accounting Officer
Sell
Tax related
1,199$1.31$1,570.6915,130

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.